Acrolein depletes the neuropeptides CGRP and substance P in sensory nerves in rat respiratory tract.
The mammalian respiratory tract is densely innervated by autonomic and sensory nerves around airways and blood vessels. Subsets of these nerves contain a number of putative neurotransmitter peptides, such as substance P and calcitonin gene-related peptide (CGRP) in sensory nerves and vasoactive intestinal polypeptide (VIP), possibly serving autonomic functions. CGRP is also found in endocrine cells in rat airway epithelium. These peptides are all pharmacologically potent effectors of bronchial and vascular smooth muscle and bronchial secretion. Their functions in vivo are less well established. We have therefore examined the effects of inhaled acrolein, a sensory irritant, on three pulmonary neuropeptides: CGRP, substance P, and VIP. Groups of rats (n = 3 each) were exposed for 10 min to acrolein in air (Ct = 510, 1858, and 5693 mg.min/m3) or to air alone. Fifteen minutes later they were killed (pentabarbitone IP) and their respiratory tracts were dissected and fixed in 0.4% p-benzoquinone solution. Cryostat sections were stained by indirect immunofluorescence for a general nerve marker (PGP 9.5) and neuropeptides. The acrolein-treated animals had a dose-related decrease in tracheal substance P- and CGRP-immunoreactive nerve fibers compared with controls. No change was seen in total nerve fiber distribution and number (PGP 9.5) or VIP immunoreactivity, nor in CGRP-immunoreactive epithelial endocrine cells. It is concluded that the rat tracheal peptidergic nerves are a sensitive indicator of inhaled irritant substances. Their reduced immunoreactivity may be because of a release of sensory neuropeptides that could play a role in the physiological response to irritant or toxic compounds.
Springall
D R
DR
Department of Histochemistry, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Edginton
J A
JA
Price
P N
PN
Swanston
D W
DW
Noel
C
C
Bloom
S R
SR
Polak
J M
JM
D000171:Acrolein / Q000008:administration & dosage / Q000633:toxicity*; D000280:Administration, Inhalation; D000447:Aldehydes / Q000633:toxicity*; D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D008168:Lung / Q000294:innervation*; D009412:Nerve Fibers / Q000032:analysis* / Q000276:immunology / Q000473:pathology; D009479:Neuropeptides; D051381:Rats; D013373:Substance P / Q000032:analysis / Q000187:drug effects*; D014132:Trachea / Q000294:innervation*; D043222:Ubiquitin Thiolesterase; D014660:Vasoactive Intestinal Peptide / Q000032:analysis / Q000187:drug effects*
D000447:Aldehydes; D009479:Neuropeptides; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D000171:Acrolein; D043222:Ubiquitin Thiolesterase; D015740:Calcitonin Gene-Related Peptide